118 related articles for article (PubMed ID: 7767257)
1. Is Hodgkin's disease a unique entity?
Pileri SA; Poggi S; Sabattini E; De Vivo A; Falini B; Stein H
Leuk Lymphoma; 1995; 15 Suppl 1():3-6. PubMed ID: 7767257
[TBL] [Abstract][Full Text] [Related]
2. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
3. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
Harris NL
Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
[TBL] [Abstract][Full Text] [Related]
4. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
[TBL] [Abstract][Full Text] [Related]
5. [Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].
Hartmann S; Hansmann ML
Pathologe; 2017 Feb; 38(1):3-10. PubMed ID: 27999937
[TBL] [Abstract][Full Text] [Related]
6. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
7. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
[TBL] [Abstract][Full Text] [Related]
8. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
Frizzera G
Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
[TBL] [Abstract][Full Text] [Related]
9. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
[TBL] [Abstract][Full Text] [Related]
10. Treatment of grey zone lymphomas.
Fisher RI
Ann Oncol; 1998; 9 Suppl 5():S121-3. PubMed ID: 9926250
[TBL] [Abstract][Full Text] [Related]
11. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
13. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
14. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
15. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's lymphoma: the pathologist's viewpoint.
Pileri SA; Ascani S; Leoncini L; Sabattini E; Zinzani PL; Piccaluga PP; Pileri A; Giunti M; Falini B; Bolis GB; Stein H
J Clin Pathol; 2002 Mar; 55(3):162-76. PubMed ID: 11896065
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-predominance Hodgkin's disease.
Poppema S
Semin Diagn Pathol; 1992 Nov; 9(4):257-64. PubMed ID: 1480848
[TBL] [Abstract][Full Text] [Related]
20. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
